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Abstract 
Comparison of profiles of radioactive peptides resolved by HPLC from tryptic digests of the bovine heart FrATPase depleted of nucleotides 
(nd-MF0 which had been photoinactivated with 2-N3-[fl-32p]ADP, on the one hand, and 2-[8-3H]ADP, on the other, shows that the fl phosphate of 
ADP tethered to tyrosine-f1345 is slowly hydrolyzed in the presence of Mg 2÷. When nd-MFl was photoinactivated with 2-N3-[8-3H]ADP in the absence 
of Mg 2+, hydrolysis of the fl phosphate from ADP tethered to tyrosine-f1345 was not observed. Subsequent addition of Mg 2÷ initiated conversion 
of ADP tethered to tyrosine-f1345 to tethered AMP suggesting that functional groups at the catalytic site participate in the hydrolytic reaction. 
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1. Introduction 
The FoFrATP synthases catalyze the condensation f
ADP with Pi which is driven by proton electrochemical 
gradients generated by electron transport processes in 
energy transducing membranes [1]. The Fo moiety acts 
as a transmembrane proton channel, whereas the F~ moi- 
ety, which is peripheral to the membrane, bears the cat- 
alytic sites. When FI is removed from Fo in soluble form, 
it functions only as an ATPase. F~-ATPases are com- 
posed of five polypeptides in a stoichiometry of ~3f1375e 
and have molecular weights of about 380,000 [2]. They 
contain six binding sites for nucleotides. Three of these 
are potential catalytic sites [3]. Since a clear functional 
role for the other three sites has not been defined, they 
are called noncatalytic nucleotide binding sites. How- 
ever, it is clear that these sites modulate FrATPases 
under in vitro conditions [4-8]. 
Whereas the catalytic sites reside mostly, if not en- 
tirely, in fl subunits [9,10], the noncatalytic s tes clearly 
span o~ and fl subunits. The major part of noncatalytic 
sites is in 0~ subunits, but the adenine moiety of adenine 
nucleotides bound to these sites interacts with a domain 
near the C-termini offl  subunits [11-14]. Hence, when 
enzyme is irradiatated after loading catalytic sites with 
2-N3-AD(T)P, tyrosine-f1345 is derivatized, whereas 
when irradiation follows loading of noncatalytic sites, 
tyrosine-f1368 is labeled [15,16]. 
After photoinactivating the CF1-ATPase with 2-N3- 
AD(T)P, Melese et al. [17] detected by two-dimensional 
gel electrophoresis what appeared to be AMP covalently 
bound to a catalytic site. They suggested that the co- 
valently bound AMP could arise from covalently bound 
ADP by hydrolysis or by a transphosphorylation reac- 
tion akin to that of adenylate kinase. It was suggested 
earlier by Cross et al. [15] that the two nucleotide binding 
sites on the fl subunit might be sufficiently close to allow 
transphosphorylation between adenine nucleotides 
bound to adjacent catalytic and noncatalytic sites. More 
recently, Vogel and Cross [18], on the basis of inhibition 
of MF1 with his-adenosine polyphosphates and homol- 
ogy of the fl subunit with adenylate kinase, presented a 
model which places nucleotides bound to catalytic and 
noncatalytic binding sites on a single fl subunit in an 
orientation that would allow an adenylate kinase-like 
transphosphorylation. 
We report here that irradiation of nucleotide depleted 
MF1 (nd-MF0 with 2-N3-[8-3H]ADP in the presence of 
Mg 2+ leads to detection of part of the photoaffinity label 
tethered at  catalytic site as [8-3H]AMP. However, the 
[8-3H]AMP derivative isdetected even when noncatalytic 
sites are empty, therefore xcluding a transphosphoryla- 
tion mechanism. Instead, the [8-3H]AMP detected at the 
catalytic site arises from Mg2+-dependent hydrolysis of 
[8-3H]ADP tethered to the catalytic site during and sub- 
sequent to irradiation. 
*Corresponding author. Fax: (1) (619) 534 7390. 
Abbreviations: MF1, the bovine heart mitochondrial F1-ATPase; nd- 
MF~, the MFrATPase depleted of endogenous nucleotides; CFI, the 
FI-ATPase from spinach chloroplasts; and HPLC, high performance 
liquid chromatography. 
2. Materials and methods 
MFI was prepared from bovine heart mitochondria with a previously 
described modification [19] of the method of Knowles and Penefsky [20] 
and was depleted of endogenous nucleotides by two successive passes 
through a Sephadex G-50-80 column equilibrated with 50% glycerol 
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(v/v) as described by Garrett and Penefsky [21]. Protein concentrations 
were determined by the Bicinchoninic acid method escribed by Smith 
et al. [22]. 
The synthesis and purifieation of 2-N3-[B-32p]ADP was performed as 
described previously [8]. The same procedure was used to synthesize 
2-N3-[8-3H]ADP except hat 2-Cl-[8-3H]adenosine (10Ci]mmol) from 
Moravek Biocbemicals was used as starting material [24]. The concen- 
tration of 2-N3-~-32P]ADP or2-N3-[8-3H]ADP was deterimed in 0.1 M 
HC! at 274 nm (e = 15,200 M -1 "era -1) [24]. 
Irradiation, trypsin digestion and separation of tryptic peptides by 
HPLC were carried out as previously described [8]. The C4 reversed- 
phase column (Brownlee; 220 x 4.6 ram, 7 mm particle size) was con- 
netted to a guard column (Brownlce; 30 x 4.6 ram, 7 mm particle size) 
and developed with a gradient of CH3CN into 0.1% HCI as follows: 
0-10 re_in, 0% CH3CN; 10-100 min, 0-24% CH3CN; 100-115 min, 
24-48% CHaCN; and 115-120 min, 48-80% CH3CN [8]. 
Biochemieals were purchased from Sigma Chemical Company. Bi- 
cinchoninic acid was from Pierce Chemical Company. Radioactivity 
was detected with a Packard 1600 TR liquid scintillation counter using 
Ecoscint from National Diagnostics. 
3. Results 
When a trypt ic digest prepared f rom nd-MF l  which 
had been photo inact ivated with 200 pM 2-N3- ~-  
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Fig. 1. Resolution by reversed-phase HPLC of radioactive peptides in 
a tryptic digest of nd-MF~ photoinactivated with 2-N3-[fl-32p]ADP or
2-N3-[8-3H]ADP inthe presence of Mg 2+. (A) A 125 gl solution contain- 
ing 3 gM nd-MF, 200 gM 2-N3-[B-32P]ADP, 2.5 mM MgC12, 0.48 mM 
EDTA, 12.6% glycerol (w/v) and 90 mM Tris-SO4, pH 8.0, was incu- 
bated at 23°C at which time it was irradiated for 40 min. (B) The 
conditions were the same as in A except 225 gM 2-N3-[8-3H]ADP was 
used instead of 2-N3-[B-32p]ADP. Irradiation, preparation a d fraction- 
ation of the tryptic digests were carried out as previously described [8].
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Fig. 2. Mg2+-induced transformation f [8-3H]ADP tethered to the 
catalytic site of nd-MFl to tethered [8-3H]AMP. The experimental con- 
ditions were the same as described in Fig. 1 except that the reaction 
mixture contained 90 pM 2-N3-[8-3H]ADP in the absence of Mg 2÷. 
After irradiation, MgC12 was added to a final concentration f 2.5 mM 
to one half of the reaction mixture (Profile B). For a control, the other 
half was diluted by the same amount with water (Profile A). The 
samples were then incubated for 40 rain at 23°C, at which time they 
were prepared for tryptic digestion as previously described [8].
versed-phase HPLC,  two major  peaks of  radioact iv i ty 
were resolved as i l lustrated in Fig. 1. Previous studies 
[8,15] have shown that the peak eluting at about  61 min 
is the tryptic peptide derived f rom the noncatalyt ic  bind- 
ing site which is derivatized at Y-t368, whereas the peak 
eluting at about  86 min contains the peptide derived from 
the catalytic site which is labeled at Y-t345. When a 
tryptic digest of  nd-MF1 which had been photoinact i -  
vated with 225 gM 2-N3-[8-3H]ADP was submitted to 
reversed-phase HPLC under the same condit ions, a 
major  peak of  radioact iv i ty eluting at about  81 and a 
minor  one eluting at 86 min were detected as i l lustrated 
in Fig. lB. In contrast,  the peak eluting at 81 min was 
not  detected in a tryptic digest of  nd-MF1 photoinact i -  
vated with 90 gM 2-N3-[8-3H]ADP in the absence of  
Mg 2÷ as shown in Fig. 2A. However, when a sample of  
the same inactivat ion mixture was incubated for 40 min 
with 2.5 mM Mg 2+ pr ior  to digestion with trypsin, the 
radioact iv i ty associated with Y-t345 eluted at 81 and 86 
min as i l lustrated in Fig. 2B. This indicates that Mg 2+ 
promotes conversion of  the original derivative of  Y-t345 
to one that has lower affinity for the reversed-phase ma- 
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trix. The peak eluting at about 81 rain is not detected in
tryptic digests prepared from nd-MF~ inactivated with 
2-N3-[fl-32p]ADP, Therefore, loss of the fl phosphate is
responsible for the conversion. Fig. 3 shows that sub- 
stantial loss of the fl phosphate from covalently bound 
[8-3H]ADP occurs within 15 min after introducing M  2+. 
However, the conversion slows considerably after 15 
min. 
To determine whether conversion of [8-3H]ADP 
covalently bound to Y-f1345 to covalently bound 
[8-3H]AMP involves transphosphorylation to ADP non- 
covalently bound to a noncatalytic site as postulated by 
Melese et al. [17], 3 gM nd-MFl was photoinactivated 
with 3/aM 2-N3-[8-3H]ADP in the presence of Mg 2+. 
These conditions hould allow exclusive labeling of a 
catalytic site as previously reported [25]. That this is the 
case is illustrated by Fig. 4 which shows the profile of 
radioactivity obtained after submitting a tryptic digest of 
enzyme photolabeled with stoichiometric 2-N3-[8- 
3H]ADP to HPLC. Only slight labeling of the noncata- 
lytic site occurs under these conditions indicating that 
the photolabel is bound nearly exclusively to a catalytic 
site. Nevertheless, most of the labeled Y-f1345 is present 
as the [8-3H]AMP derivative, indicating that a nucleotide 
bound to an adjacent noncatalytic site does not partici- 
pate in loss of the fl phosphate. 
4. Discussion 
It is clear from the results presented that the 
[8-3H]AMP-derivative of Y-f1345 detected on photo- 
inactivation of MF~ with 2-N3-[8-3H]ADP arises from 
Mg 2+- dependent hydrolysis of the fl phosphate of teth- 
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Fig. 3. Conversion of [8JH]ADP tethered to Y-f1345 to tethered [8- 
3H]AMP after adding Mg ~+ to nd-MF~ which had been photoinacti- 
vated with 2-N3-[8-3H]ADP. The experimental conditions were the 
same as in Fig. 2 except hat l l2pM 2-N3-[8-3H]ADP was used. After 
irradiation, a sample was removed for a control. To the remaining 
solution, MgCl2 was added to a final concentration f 2.5 mM. At the 
times indicated, samples were removed from the reaction mixture and 
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Fig. 4. The fl phosphate of [8JH]ADP tethered to Y-f1345 is hydrolyzed 
when noneatalytic sites are empty. The experimental conditions were 
the same as those described in Fig. 1 except hat the reaction mixtures 
contained 3gM 2-N3-[8-3H]ADP. 
ered [8- 3H]ADE Since AMP has very low affinity for F1 
[26], hydrolysis probably occurs after derivatization. 
This is supported by the observation that addition of 
Mg 2+ to enzyme derivatized with 2-N3-[8-aH]ADP in the 
absence of the divalent metal ion initiates loss of the fl 
phosphate. It is interesting that an [8-3H]AMP derivative 
is not detected on Y-f1368 which is part of the noncata- 
lytic site. Melese et al. [17] reported a similar observation 
with CFv This suggests that hydrolysis of the fl phos- 
phate from ADP tethered to Y-f1345 at a catalytic site 
might involve participation of amino acid side chains in 
the immediate vicinity of the covalently bound ligand. 
Supporting this contention is the observation that con- 
version of tethered ADP to tethered AMP is nearly com- 
plete when Mg 2+ is included uring the 40 min irradia- 
tion used to derivatize the enzyme, whereas the rate of 
conversion drops off rapidly with time when Mg 2+ is 
added after irradiation. The decrease in rate of conver- 
sion observed might reflect unfolding of the derivatized 
enzyme to a form that can no longer utilize amino acid 
side chains at the catalytic site to hydrolyze the fl phos- 
phate tethered to Y-f1345. This raises the intriguing pos- 
sibility that ADP tethered to Y-f1345 at a catalytic site 
might be distorted in a position that would allow the fl 
phosphate to occupy the site normally occupied by the 
y phosphate when ATP is bound to the unmodified cat- 
alytic site. In any event, no matter what mechanism is 
responsible for conversion of ADP tethered to Y-f1345 to 
tethered AMP, transphosphorylation to nucleotide 
bound to a noncatalytic site is not involved. Therefore, 
the detection of AMP covalently bound to the catalytic 
site of MF~ as described here or to the catalytic site of 
CF~ as described by Melese et al. [17] cannot be taken 
as support for the regulatory transphosphorylation 
mechanism postulated by Cross et al. [15] and Vogel and 
Cross [18]. Furthermore, it is clear from the results pre- 
sented that 2-N3-[8-3H]AD(T)P or 2-N3-[~-32p]AD(T)P 
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[27] are the preferred reagents for correlating the number 
of catalytic sites modified with the extent of inactivation 
when F~-ATPases are photoinactivated with 2-N3- 
AD(T)P. 
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